Showing results (101-110 of 245) with videos related to

Sort By:
Pageof 25
Clinical and Experimental Nephrology|December 27, 2019
Blood pressure control in chronic kidney disease according to underlying renal disease: the Fukushima CKD cohortAya Nakajima, Kenichi Tanaka, Hirotaka Saito, et al.
Diabetes Care|August 25, 2025
Prediction of Sarcopenia Onset in Type 2 Diabetes Using Urinary Titin Levels: A Japanese Prospective Cohort StudyHayato Tanabe, Yoshinori Takiguchi, Rie Tsutsumi, et al.
The British Journal of Nutrition|August 13, 2013
Effects of the brown rice diet on visceral obesity and endothelial function: the BRAVO studyMichio Shimabukuro, Moritake Higa, Rie Kinjo, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|May 20, 2024
Geriatric Nutritional Risk Index is associated with adverse outcomes in patients with hypertension: the Fukushima Cohort studyKenichi Tanaka, Hiroshi Kimura, Hiroki Ejiri, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|January 21, 2020
Association of Local Epicardial Adipose Tissue Depots and Left Ventricular Diastolic Performance in Patients With Preserved Left Ventricular Ejection FractionGulinu Maimaituxun, Hirotsugu Yamada, Daiju Fukuda, et al.
Cardiovascular Diabetology|May 2, 2025
Impact of baseline left ventricular ejection fraction and body mass index on the effect of 24-week Ipragliflozin treatment on left ventricular diastolic function in patients with type 2 diabetes and chronic kidney disease: insights from the PROCEED trialHiroki Teragawa, Atsushi Tanaka, Kanae Takahashi, et al.
Cardiovascular Diabetology|June 29, 2021
Reduction of estimated fluid volumes following initiation of empagliflozin in patients with type 2 diabetes and cardiovascular disease: a secondary analysis of the placebo-controlled, randomized EMBLEM trialAtsushi Tanaka, Michio Shimabukuro, Hiroki Teragawa, et al.
Cardiovascular Diabetology|August 1, 2021
Comparison of the clinical effect of empagliflozin on glycemic and non-glycemic parameters in Japanese patients with type 2 diabetes and cardiovascular disease treated with or without baseline metforminAtsushi Tanaka, Michio Shimabukuro, Hiroki Teragawa, et al.
Frontiers in Cardiovascular Medicine|February 1, 2021
Deleterious Effects of Epicardial Adipose Tissue Volume on Global Longitudinal Strain in Patients With Preserved Left Ventricular Ejection FractionGulinu Maimaituxun, Kenya Kusunose, Hirotsugu Yamada, et al.
Scientific Reports|June 14, 2019
Randomized Evaluation of Anagliptin vs Sitagliptin On low-density lipoproteiN cholesterol in diabetes (REASON) Trial: A 52-week, open-label, randomized clinical trialTakeshi Morimoto, Ichiro Sakuma, Mio Sakuma, et al.
Pageof 25